These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30416049)

  • 1. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.
    Olgasi C; Talmon M; Merlin S; Cucci A; Richaud-Patin Y; Ranaldo G; Colangelo D; Di Scipio F; Berta GN; Borsotti C; Valeri F; Faraldi F; Prat M; Messina M; Schinco P; Lombardo A; Raya A; Follenzi A
    Stem Cell Reports; 2018 Dec; 11(6):1391-1406. PubMed ID: 30416049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A.
    Rose M; Gao K; Cortez-Toledo E; Agu E; Hyllen AA; Conroy K; Pan G; Nolta JA; Wang A; Zhou P
    Stem Cells Transl Med; 2020 Jun; 9(6):686-696. PubMed ID: 32162786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.
    Neumeyer J; Lin RZ; Wang K; Hong X; Hua T; Croteau SE; Neufeld EJ; Melero-Martin JM
    Blood Adv; 2019 Dec; 3(24):4166-4176. PubMed ID: 31851760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs.
    Wu Y; Hu Z; Li Z; Pang J; Feng M; Hu X; Wang X; Lin-Peng S; Liu B; Chen F; Wu L; Liang D
    Sci Rep; 2016 Jan; 6():18865. PubMed ID: 26743572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs.
    Son JS; Park CY; Lee G; Park JY; Kim HJ; Kim G; Chi KY; Woo DH; Han C; Kim SK; Park HJ; Kim DW; Kim JH
    Biomaterials; 2022 Apr; 283():121429. PubMed ID: 35217482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.
    Gong J; Yang R; Zhou M; Chang LJ
    Mol Med; 2023 Jun; 29(1):74. PubMed ID: 37308845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice.
    Merlin S; Famà R; Borroni E; Zanolini D; Bruscaggin V; Zucchelli S; Follenzi A
    Blood Adv; 2019 Mar; 3(5):825-838. PubMed ID: 30862611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.
    Kochat V; Kanjirakkuzhiyil S; Baligar P; Nagarajan P; Mukhopadhyay A
    Stem Cell Res Ther; 2015 Jul; 6(1):129. PubMed ID: 26152192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A.
    Kumar P; Gao K; Wang C; Pivetti C; Lankford L; Farmer D; Wang A
    Cell Transplant; 2018 Jan; 27(1):130-139. PubMed ID: 29562772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the human F8 at the multicopy rDNA locus in Hemophilia A patient-derived iPSCs using TALENickases.
    Pang J; Wu Y; Li Z; Hu Z; Wang X; Hu X; Wang X; Liu X; Zhou M; Liu B; Wang Y; Feng M; Liang D
    Biochem Biophys Res Commun; 2016 Mar; 472(1):144-9. PubMed ID: 26921444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
    Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34
    Qin M; Guan X; Wang H; Zhang Y; Shen B; Zhang Q; Dai W; Ma Y; Jiang Y
    Stem Cell Res Ther; 2017 Feb; 8(1):25. PubMed ID: 28173870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells.
    Gao K; Kumar P; Cortez-Toledo E; Hao D; Reynaga L; Rose M; Wang C; Farmer D; Nolta J; Zhou J; Zhou P; Wang A
    Stem Cell Res Ther; 2019 Jan; 10(1):34. PubMed ID: 30670078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
    Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
    Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
    Xu D; Alipio Z; Fink LM; Adcock DM; Yang J; Ward DC; Ma Y
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):808-13. PubMed ID: 19139414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system.
    Yakura Y; Ishihara C; Kurosaki H; Kazuki Y; Komatsu N; Okada Y; Doi T; Takeya H; Oshimura M
    Biochem Biophys Res Commun; 2013 Feb; 431(2):336-41. PubMed ID: 23291180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Alphoid
    Ponomartsev SV; Sinenko SA; Skvortsova EV; Liskovykh MA; Voropaev IN; Savina MM; Kuzmin AA; Kuzmina EY; Kondrashkina AM; Larionov V; Kouprina N; Tomilin AN
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.
    Zanolini D; Merlin S; Feola M; Ranaldo G; Amoruso A; Gaidano G; Zaffaroni M; Ferrero A; Brunelleschi S; Valente G; Gupta S; Prat M; Follenzi A
    Haematologica; 2015 Jul; 100(7):881-92. PubMed ID: 25911555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.